Report Detail

Pharma & Healthcare Global Orodispersible Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3693751
  • |
  • 13 August, 2024
  • |
  • Global
  • |
  • 112 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Orodispersible Tablets market size was valued at USD 15760 million in 2023 and is forecast to a readjusted size of USD 33130 million by 2030 with a CAGR of 11.2% during review period.
An Orodispersible Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The orodispersible tablets market is driven by the increasing demand for patient-friendly and convenient drug delivery systems and the growing focus on improving medication adherence. Orodispersible tablets, also known as orally disintegrating tablets or melt-in-mouth tablets, are designed to dissolve rapidly in the mouth without the need for water, making them easier to swallow, especially for patients who have difficulty swallowing conventional tablets or capsules. The rise in the aging population and the prevalence of chronic diseases contribute to market growth, as these patient populations often face challenges in taking oral medications. Moreover, advancements in formulation technology and taste-masking techniques have improved the palatability and acceptance of orodispersible tablets. However, the market also faces challenges, including the cost of development and manufacturing of specialized formulations and addressing stability and shelf-life concerns. Additionally, obtaining regulatory approvals and ensuring consistent quality and performance can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer a diverse range of orodispersible tablet formulations, collaborate with healthcare providers to address specific patient needs, and address the challenges to meet the increasing demand for patient-friendly and effective drug delivery solutions.
The Global Info Research report includes an overview of the development of the Orodispersible Tablets industry chain, the market status of CNS Diseases (Anti-Psychotics Drug, Anti-Epileptics Drug), Gastrointestinal Diseases (Anti-Psychotics Drug, Anti-Epileptics Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Orodispersible Tablets.
Regionally, the report analyzes the Orodispersible Tablets markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Orodispersible Tablets market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Orodispersible Tablets market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Orodispersible Tablets industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Anti-Psychotics Drug, Anti-Epileptics Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Orodispersible Tablets market.
Regional Analysis: The report involves examining the Orodispersible Tablets market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Orodispersible Tablets market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Orodispersible Tablets:
Company Analysis: Report covers individual Orodispersible Tablets manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Orodispersible Tablets This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (CNS Diseases, Gastrointestinal Diseases).
Technology Analysis: Report covers specific technologies relevant to Orodispersible Tablets. It assesses the current state, advancements, and potential future developments in Orodispersible Tablets areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Orodispersible Tablets market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Orodispersible Tablets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Market segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Major players covered
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orodispersible Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Orodispersible Tablets, with price, sales, revenue and global market share of Orodispersible Tablets from 2019 to 2024.
Chapter 3, the Orodispersible Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orodispersible Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Orodispersible Tablets market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Orodispersible Tablets.
Chapter 14 and 15, to describe Orodispersible Tablets sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Orodispersible Tablets
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Orodispersible Tablets Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Anti-Psychotics Drug
    • 1.3.3 Anti-Epileptics Drug
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Orodispersible Tablets Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 CNS Diseases
    • 1.4.3 Gastrointestinal Diseases
    • 1.4.4 CVS Diseases
    • 1.4.5 Other
  • 1.5 Global Orodispersible Tablets Market Size & Forecast
    • 1.5.1 Global Orodispersible Tablets Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Orodispersible Tablets Sales Quantity (2019-2030)
    • 1.5.3 Global Orodispersible Tablets Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Teva
    • 2.1.1 Teva Details
    • 2.1.2 Teva Major Business
    • 2.1.3 Teva Orodispersible Tablets Product and Services
    • 2.1.4 Teva Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Teva Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Orodispersible Tablets Product and Services
    • 2.2.4 Merck Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Mylan
    • 2.3.1 Mylan Details
    • 2.3.2 Mylan Major Business
    • 2.3.3 Mylan Orodispersible Tablets Product and Services
    • 2.3.4 Mylan Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Mylan Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Orodispersible Tablets Product and Services
    • 2.4.4 Pfizer Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 Johnson and Johnson
    • 2.5.1 Johnson and Johnson Details
    • 2.5.2 Johnson and Johnson Major Business
    • 2.5.3 Johnson and Johnson Orodispersible Tablets Product and Services
    • 2.5.4 Johnson and Johnson Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Johnson and Johnson Recent Developments/Updates
  • 2.6 GSK
    • 2.6.1 GSK Details
    • 2.6.2 GSK Major Business
    • 2.6.3 GSK Orodispersible Tablets Product and Services
    • 2.6.4 GSK Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 GSK Recent Developments/Updates
  • 2.7 Otsuka
    • 2.7.1 Otsuka Details
    • 2.7.2 Otsuka Major Business
    • 2.7.3 Otsuka Orodispersible Tablets Product and Services
    • 2.7.4 Otsuka Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Otsuka Recent Developments/Updates
  • 2.8 Eli Lilly and Company
    • 2.8.1 Eli Lilly and Company Details
    • 2.8.2 Eli Lilly and Company Major Business
    • 2.8.3 Eli Lilly and Company Orodispersible Tablets Product and Services
    • 2.8.4 Eli Lilly and Company Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Eli Lilly and Company Recent Developments/Updates
  • 2.9 AstraZeneca
    • 2.9.1 AstraZeneca Details
    • 2.9.2 AstraZeneca Major Business
    • 2.9.3 AstraZeneca Orodispersible Tablets Product and Services
    • 2.9.4 AstraZeneca Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 AstraZeneca Recent Developments/Updates
  • 2.10 Bristol-Myers Squibb
    • 2.10.1 Bristol-Myers Squibb Details
    • 2.10.2 Bristol-Myers Squibb Major Business
    • 2.10.3 Bristol-Myers Squibb Orodispersible Tablets Product and Services
    • 2.10.4 Bristol-Myers Squibb Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.11 Conquer
    • 2.11.1 Conquer Details
    • 2.11.2 Conquer Major Business
    • 2.11.3 Conquer Orodispersible Tablets Product and Services
    • 2.11.4 Conquer Orodispersible Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Conquer Recent Developments/Updates

3 Competitive Environment: Orodispersible Tablets by Manufacturer

  • 3.1 Global Orodispersible Tablets Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Orodispersible Tablets Revenue by Manufacturer (2019-2024)
  • 3.3 Global Orodispersible Tablets Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Orodispersible Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Orodispersible Tablets Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Orodispersible Tablets Manufacturer Market Share in 2023
  • 3.5 Orodispersible Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Orodispersible Tablets Market: Region Footprint
    • 3.5.2 Orodispersible Tablets Market: Company Product Type Footprint
    • 3.5.3 Orodispersible Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Orodispersible Tablets Market Size by Region
    • 4.1.1 Global Orodispersible Tablets Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Orodispersible Tablets Consumption Value by Region (2019-2030)
    • 4.1.3 Global Orodispersible Tablets Average Price by Region (2019-2030)
  • 4.2 North America Orodispersible Tablets Consumption Value (2019-2030)
  • 4.3 Europe Orodispersible Tablets Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Orodispersible Tablets Consumption Value (2019-2030)
  • 4.5 South America Orodispersible Tablets Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Orodispersible Tablets Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Orodispersible Tablets Sales Quantity by Type (2019-2030)
  • 5.2 Global Orodispersible Tablets Consumption Value by Type (2019-2030)
  • 5.3 Global Orodispersible Tablets Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Orodispersible Tablets Sales Quantity by Application (2019-2030)
  • 6.2 Global Orodispersible Tablets Consumption Value by Application (2019-2030)
  • 6.3 Global Orodispersible Tablets Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Orodispersible Tablets Sales Quantity by Type (2019-2030)
  • 7.2 North America Orodispersible Tablets Sales Quantity by Application (2019-2030)
  • 7.3 North America Orodispersible Tablets Market Size by Country
    • 7.3.1 North America Orodispersible Tablets Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Orodispersible Tablets Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Orodispersible Tablets Sales Quantity by Type (2019-2030)
  • 8.2 Europe Orodispersible Tablets Sales Quantity by Application (2019-2030)
  • 8.3 Europe Orodispersible Tablets Market Size by Country
    • 8.3.1 Europe Orodispersible Tablets Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Orodispersible Tablets Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Orodispersible Tablets Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Orodispersible Tablets Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Orodispersible Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Orodispersible Tablets Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Orodispersible Tablets Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Orodispersible Tablets Sales Quantity by Type (2019-2030)
  • 10.2 South America Orodispersible Tablets Sales Quantity by Application (2019-2030)
  • 10.3 South America Orodispersible Tablets Market Size by Country
    • 10.3.1 South America Orodispersible Tablets Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Orodispersible Tablets Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Orodispersible Tablets Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Orodispersible Tablets Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Orodispersible Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Orodispersible Tablets Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Orodispersible Tablets Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Orodispersible Tablets Market Drivers
  • 12.2 Orodispersible Tablets Market Restraints
  • 12.3 Orodispersible Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Orodispersible Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Orodispersible Tablets
  • 13.3 Orodispersible Tablets Production Process
  • 13.4 Orodispersible Tablets Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Orodispersible Tablets Typical Distributors
  • 14.3 Orodispersible Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Orodispersible Tablets. Industry analysis & Market Report on Orodispersible Tablets is a syndicated market report, published as Global Orodispersible Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Orodispersible Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,780.52
    4,170.78
    5,561.04
    3,358.20
    5,037.30
    6,716.40
    547,160.40
    820,740.60
    1,094,320.80
    298,270.80
    447,406.20
    596,541.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report